Arkema SA:企業の戦略・SWOT・財務情報

◆英語タイトル:Arkema SA - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C0803
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:48
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:化学
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Arkema SA – Strategy, SWOT and Corporate Finance Report
Summary

Arkema SA – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Arkema SA (Arkema or ‘the company’) is engaged in the manufacturing and supplying of chemical products. The company provides biobased materials, composites, coatings, adhesives, health care and sports equipment solutions. It operates across Europe, Asia Pacific, Africa and the Middle East, and the Americas. Arkema is headquartered in Colombes, France.

Scope

- Detailed information on Arkema SA required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Arkema SA in the form of a SWOT analysis
- An in-depth view of the business model of Arkema SA including a breakdown and examination of key business segments
- Intelligence on Arkema SA’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Arkema SA, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Arkema SA and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Arkema SA as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Arkema SA’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Arkema SA: Company Overview 9
Arkema SA: Overview and Key Facts 9
Arkema SA: Overview 9
Arkema SA: Key Facts 9
Arkema SA: Key Employees 10
Arkema SA: Key Employee Biographies 12
Arkema SA: Major Products and Services 16
Arkema SA: Company History 18
Arkema SA: Management Statement 23
Arkema SA: Locations and Subsidiaries 25
Arkema SA: Key Competitors 26
Arkema SA: Company Analysis 27
Arkema SA: Business Description 27
Arkema SA: SWOT Analysis 29
Arkema SA: SWOT Overview 29
Arkema SA: Strengths 29
Arkema SA: Weaknesses 30
Arkema SA: Opportunities 31
Arkema SA: Threats 31
Arkema SA: Corporate Financial Deals Activity 33
Arkema SA: Financial Deals Overview 33
Arkema SA: Targets and Partners 34
Arkema SA: Top Deals 2014 – 2018YTD* 35
Arkema SA: Advisors 36
Arkema SA: Top Legal Advisors 36
Arkema SA: Mergers and Acquisitions 37
Arkema SA: Divestments 38
Arkema SA: Recent Developments 39
Arkema SA: News and Events Summary 39
Arkema SA: Business Expansion 42
Arkema SA: Contracts 43
Arkema SA: Corporate Governance 44
Arkema SA: Financial Performance 44
Arkema SA: Strategy and Operations 45
Appendix 46
Contact Us 46
Methodology 46
About MarketLine 47

List of Tables
Table 1: Arkema SA: Key Facts
Table 2: Arkema SA: Key Employees
Table 3: Arkema SA: Locations and Subsidiaries
Table 4: Arkema SA: Key Competitors
Table 5: Arkema SA: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 6: Arkema SA: M&A Average Deal Size - Value (US$m)
Table 7: Arkema SA: Targets and Partners
Table 8: Arkema SA: Top Deals 2014 - 2018YTD*
Table 9: Arkema SA: Legal Advisor Ranking by Value (US$m)
Table 10: Arkema SA: M&A Volume and Value Trend (2014 - YTD*2018)
Table 11: Arkema SA: M&A Activity by Geography (2014 - YTD*2018)
Table 12: Arkema SA: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 13: Arkema SA: News and Events Summary
Table 14: Arkema SA: Business Expansion
Table 15: Arkema SA: Contracts
Table 16: Arkema SA: Corporate Governance
Table 17: Arkema SA: Financial Performance
Table 18: Arkema SA: Strategy and Operations

List of Figures
Figure 1: Arkema SA: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 2: Arkema SA: M&A Average Deal Size - Value (US$m)
Figure 3: Arkema SA: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 4: Arkema SA: M&A Activity by Geography (2014 - YTD*2018)
Figure 5: Arkema SA: Divestments Volume and Value Trend (2014 - YTD*2018)

★海外企業調査レポート[Arkema SA:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Patel Engineering Ltd:企業の戦略・SWOT・財務情報
    Patel Engineering Ltd - Strategy, SWOT and Corporate Finance Report Summary Patel Engineering Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • ARCA biopharma Inc (ABIO):医療機器:M&Aディール及び事業提携情報
    Summary ARCA Biopharma Inc (ARCA), formerly Nuvelo Inc is a developer of genetically targeted therapies for cardiovascular diseases. The company’s product candidate include Gencaro, a mild vasodilator and investigational pharmacologically unique beta-blocker that is being developed for the treatment …
  • ProQR Therapeutics NV (PRQR):製薬・医療:M&Aディール及び事業提携情報
    Summary ProQR Therapeutics NV (ProQR) is a clinical-stage biotech company that discovers and develops drugs for the treatment of genetic disorders. The company’s lead product candidate includes QR-010, a RNA-based oligonucleotide used for the treatment of cystic fibrosis; QR-110, an oligonucleotide …
  • Moderna Therapeutics Inc:企業のM&A・事業提携・投資動向
    Moderna Therapeutics Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Moderna Therapeutics Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Gold Fields Ltd:戦略・SWOT・企業財務分析
    Gold Fields Ltd - Strategy, SWOT and Corporate Finance Report Summary Gold Fields Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Globus Medical Inc (GMED):企業の財務・戦略的SWOT分析
    Globus Medical Inc (GMED) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Ohr Pharmaceutical Inc (OHRP):企業の財務・戦略的SWOT分析
    Summary Ohr Pharmaceutical Inc (Ohr), formerly BBM Holdings Inc, is a pharmaceutical company that develops novel therapies for ophthalmic diseases. The company offers products such as squalamine lactate ophthalmic solution and SKS sustained release technology products. Its squalamine lactate ophthal …
  • Stada Arzneimittel AG (SAZ)-医療機器分野:企業M&A・提携分析
    Summary Stada Arzneimittel AG (STADA) is a pharmaceutical company that manufacturers low-cost generics and branded over the counter products. The company develops and markets drugs with off-patent active pharmaceutical ingredients, particularly, which are free from commercial property rights. It off …
  • Moss Bros Group Plc (MOSB):企業の財務・戦略的SWOT分析
    Moss Bros Group Plc (MOSB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Office Depot, Inc.:戦略・SWOT・企業財務分析
    Office Depot, Inc. - Strategy, SWOT and Corporate Finance Report Summary Office Depot, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Morcher Gmbh:企業の製品パイプライン分析2018
    Summary Morcher Gmbh (Morcher) is a medical device company that develops, manufactures, and distributes implants for cataract surgery. The company’s products include capsular tension rings, eyejet ctr - preloaded capsular tension rings, cionni rings for scleral fixation, capsular segment for scleral …
  • Masimo Corp (MASI):企業の財務・戦略的SWOT分析
    Masimo Corp (MASI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • TOTAL S.A.:企業の戦略・SWOT・財務情報
    TOTAL S.A. - Strategy, SWOT and Corporate Finance Report Summary TOTAL S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Genomic Health Inc (GHDX)-製薬・医療分野:企業M&A・提携分析
    Summary Genomic Health Inc (Genomic Health) is a provider of genomic-based diagnostic tests and clinical laboratory services for the diagnosis of cancer. The company’s commercial product portfolio comprises Onco type DX breast cancer test, Onco type DX colon cancer test, Onco type DX prostate cancer …
  • Magnis Energy Technologies Ltd (MNS):企業の財務・戦略的SWOT分析
    Magnis Energy Technologies Ltd (MNS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Carna Biosciences Inc (4572):製薬・医療:M&Aディール及び事業提携情報
    Summary Carna Biosciences Inc (Carna) is a biotechnology company that discovers and develops drugs for the treatment of cancer and inflammatory diseases. The company offers products such as kinase proteins, biotinylated kinases, substrates, assay kits, protein substrates, inactive kinases, inactive- …
  • Group Five Ltd:企業の戦略的SWOT分析
    Group Five Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Exxon Mobil Corporation (XOM)-エネルギー分野:企業M&A・提携分析
    Summary Exxon Mobil Corporation (ExxonMobil) is an integrated oil and gas company that explores for and produces crude oil and natural gas; manufactures petroleum products; transports and sells crude oil and petroleum products; and markets natural gas and natural gas liquids. It is a major manufactu …
  • Enerplus Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Enerplus Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Enerplus Corp (Enerplus), formerly Enerplus Resources Fund is an oil and gas company that offers exploration and development services. The company provides exploration and development of natural resour …
  • Huron Consulting Group Inc:企業のM&A・事業提携・投資動向
    Huron Consulting Group Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Huron Consulting Group Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆